Bad Blood: Secrets and Lies in a Silicon Valley Startup
2.300,00 د.ج
A New York Times Bestseller
Longlisted for the Financial Times and McKinsey Business Book of the Year Award
‘Chilling . . . Reads like a West Coast version of All the President’s Men.’ New York Times Book Review
The full inside story of the breathtaking rise and shocking collapse of Theranos, the multibillion-dollar biotech startup, by the prize-winning journalist who first broke the story and pursued it to the end, despite pressure from its charismatic CEO and threats by her lawyers.
In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup “unicorn” promised to revolutionize the medical industry with a machine that would make blood testing significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes’s worth at an estimated $4.7 billion. There was just one problem: The technology didn’t work.
In Bad Blood, John Carreyrou tells the riveting story of the biggest corporate fraud since Enron, a tale of ambition and hubris set amid the bold promises of Silicon Valley.
Now to be adapted into a film, with Jennifer Lawrence to star.
A New York Times Bestseller
Longlisted for the Financial Times and McKinsey Business Book of the Year Award
‘Chilling . . . Reads like a West Coast version of All the President’s Men.’ New York Times Book Review
The full inside story of the breathtaking rise and shocking collapse of Theranos, the multibillion-dollar biotech startup, by the prize-winning journalist who first broke the story and pursued it to the end, despite pressure from its charismatic CEO and threats by her lawyers.
In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup “unicorn” promised to revolutionize the medical industry with a machine that would make blood testing significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes’s worth at an estimated $4.7 billion. There was just one problem: The technology didn’t work.
In Bad Blood, John Carreyrou tells the riveting story of the biggest corporate fraud since Enron, a tale of ambition and hubris set amid the bold promises of Silicon Valley.
Now to be adapted into a film, with Jennifer Lawrence to star.
Editeur |
---|
Produits similaires
The Uninhabitable Earth: A Story of the Future
'An epoch-defining book' Matt Haig
'If you read just one work of non-fiction this year, it should probably be this' David Sexton, Evening Standard
It is worse, much worse, than you think.
The slowness of climate change is a fairy tale, perhaps as pernicious as the one that says it isn't happening at all, and if your anxiety about it is dominated by fears of sea-level rise, you are barely scratching the surface of what terrors are possible, even within the lifetime of a teenager today.
Over the past decades, the term "Anthropocene" has climbed into the popular imagination - a name given to the geologic era we live in now, one defined by human intervention in the life of the planet. But however sanguine you might be about the proposition that we have ravaged the natural world, which we surely have, it is another thing entirely to consider the possibility that we have only provoked it, engineering first in ignorance and then in denial a climate system that will now go to war with us for many centuries, perhaps until it destroys us. In the meantime, it will remake us, transforming every aspect of the way we live-the planet no longer nurturing a dream of abundance, but a living nightmare.
In Cold Blood
An alternate cover of this ISBN can be found here.
Why We Can’t Sleep: Women’s New Midlife Crisis
Calhoun decided to find some answers. She looked into housing costs, HR trends, credit card debt averages and divorce data. At every turn, she saw a pattern: sandwiched between the Boomers and the Millennials, Gen X women were facing new problems as they entered middle age, problems that were being largely overlooked.
Speaking with women across America about their experiences as the generation raised to 'have it all,' Calhoun found that most were exhausted, terrified about money, under-employed, and overwhelmed. Instead of their issues being heard, they were told instead to lean in, take 'me-time' or make a chore chart to get their lives and homes in order.
In Why We Can't Sleep, Calhoun opens up the cultural and political contexts of Gen X's predicament and offers solutions for how to pull oneself out of the abyss - and keep the next generation of women from falling in. The result is reassuring, empowering and essential reading for all middle-aged women, and anyone who hopes to understand them.